Cheap cigarettes on www.cigarettes-shop.net/
Red Marlboro
Tobacco Regulation Strategy Recommendation (PM, '98) Source: Smokefree.net, 2004-09-15 Author: Anne Landman, Research Specialist Intro: This 23-page "privileged and confidential" Philip Morris (PM) discussion piece outlines the thinking behind Philip Morris' 180-degree turn from stringently opposing U.S. Food and Drug Administration (FDA) of cigarettes to in fact seeking such regulation, the company's logic in proceeding down this path and what the company hopes for and fears in FDA regulation. It was written in by Mark Berlind (Assistant General Counsel of Philip Morris Worldwide Regulatory Affairs) in 1998. Berlind first recaps the history of PM's opposition to FDA regulation and recommends instead that PM USA advocate for regulation as a way to maintain the status quo, or "perpetuate the existing framework's philosophy that adults continue to be permitted to assume" the inherent risks of cigarette smoking: . . . Berlind concludes that "sensible regulation would continue to permit adults to assume the inherent risks of smoking, while allocating to the government the twin tasks of ensuring that manufacturers don't created additional risk though their design and manufacturing processes, on the one hand, and continuing to conduct appropriate research about the nature of the inherent risks and keeping consumers informed of them, on the other." These limited parameters for regulation appear to be the broad goals PM seeks in FDA regulation: that such regulation will generally preserve the status quo of "adult choice" about smoking, assure cigarette manufacturers don't create any more risks than their products currently pose, to place FDA in charge of informing citizens about the risks of smoking, to prevent FDA from getting any authority to reduce or eliminate any naturally-occurring harmful constituents in cigarettes (to relegate this only to Congress).
cigarettes from